BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23760979)

  • 1. Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.
    Ke B; Wu LL; Liu N; Zhang RP; Wang CL; Liang H
    Tumour Biol; 2013 Oct; 34(5):3137-45. PubMed ID: 23760979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
    Xi W; Rui W; Fang L; Ke D; Ping G; Hui-Zhong Z
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):837-46. PubMed ID: 19034510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.
    Ru GQ; Wang HJ; Xu WJ; Zhao ZS
    Pathol Oncol Res; 2011 Jun; 17(2):341-7. PubMed ID: 21104359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
    Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
    Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
    Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
    Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
    Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
    Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
    PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients.
    Zheng Y; Wang DD; Wang W; Pan K; Huang CY; Li YF; Wang QJ; Yuan SQ; Jiang SS; Qiu HB; Chen YM; Zhang XF; Zhao BW; Mai C; Xia JC; Zhou ZW
    PLoS One; 2014; 9(4):e93073. PubMed ID: 24698999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.